1
0
May 14, 2026
NEW YORK — A massive multinational analysis encompassing more than 6.4 million adults has confirmed that two of the world’s leading cardiovascular risk calculators are remarkably effective at predicting heart disease across diverse global populations. The study, published this week in Nature Medicine, finds that the American PREVENT equations and Europe’s SCORE2 provide reliable roadmaps for preventive care, though researchers noted that a routine, inexpensive urine test could be the “missing link” to even greater accuracy for high-risk patients.
The findings offer a significant boost to clinical confidence, suggesting that these digital tools—originally developed using specific regional datasets—can be safely exported to help doctors worldwide identify who needs life-saving interventions like statins or blood pressure medication.
A New Era of Precision Prevention
For decades, the “gold standard” for heart health was a simple checklist: age, sex, smoking status, and cholesterol. However, as medical science moved toward personalized medicine, tools like the PREVENT (Predicting Risk of cardiovascular disease EVENTs) equations and SCORE2 (Systematic Coronary Risk Evaluation 2) were developed to provide a more nuanced 10-year outlook.
The new analysis, led by researchers at NYU Langone Health and involving 62 separate studies, represents one of the largest validation efforts in medical history. By pooling data from 44 observational cohorts and 18 multi-country clinical trials, researchers tracked nearly 300,000 cardiovascular events—including heart attacks, strokes, and heart failure—over an average of five years.
Key Findings at a Glance
-
High Performance: PREVENT achieved a “C-statistic” (a measure of predictive accuracy) of 0.70 for overall outcomes. It was particularly adept at spotting future heart failure, with a score of 0.78.
-
Global Versatility: Both tools performed best in primary-care settings among patients at low to moderate risk, proving they are robust enough for everyday use in a family doctor’s office.
-
The “Asian Gap”: While generally accurate, the models modestly overpredicted risk in some Asian cohorts. Experts suggest this may be due to differences in regional diet, genetics, or how different countries record medical data.
“Validating PREVENT across diverse settings was critical before we could recommend its broader international adoption,” said Dr. Josef Coresh, the study’s lead investigator and founding director of the Optimal Aging Institute at NYU Langone. “These results ease concerns about generalizability while giving us a clear path for local adjustments.”
The Power of the “Protein Check”
Perhaps the most actionable discovery in the study involves albuminuria—the presence of the protein albumin in the urine. Normally, the kidneys filter protein out, so its presence in urine is a “canary in the coal mine” for kidney damage and systemic vascular strain.
The researchers found that adding an albuminuria test to the PREVENT equations significantly sharpened the results. This was especially true for patients living with diabetes or chronic kidney disease (CKD).
“Incorporating a measure of kidney health into heart risk assessment transforms our ability to treat the whole person,” explains Dr. Coresh. Because urine albumin tests are inexpensive and already widely available, researchers argue they should be a standard part of the toolkit for reclassifying “intermediate-risk” patients into “high-risk” categories, ensuring they receive more aggressive preventive care.
Why Local Context Still Matters
Despite the overall success of the calculators, independent experts urge a “trust but verify” approach. Regional differences in obesity rates, air pollution, and even the way doctors code a “heart attack” in electronic records can skew a calculator’s math.
In some regions, the models slightly over-predicted risk, which could theoretically lead to “over-treatment”—prescribing medications to people who might not strictly need them. Conversely, under-prediction could leave vulnerable patients without protection.
“Predictive performance can vary based on the specific characteristics of a local population,” noted independent public health experts in a commentary accompanying the study. The researchers emphasized that while the global “engine” of these calculators is sound, local health systems should “recalibrate” the tools to match their specific population’s event rates.
What This Means for You
For the health-conscious consumer, this study moves heart-risk assessment from a “best guess” to a data-driven science. If you are visiting your doctor for a check-up, here is how to apply these findings:
-
Ask for the Tool: Inquire if your physician uses modern equations like PREVENT or SCORE2. These are more updated than the older “Pooled Cohort Equations” used a decade ago.
-
Discuss the Urine Test: If you have high blood pressure, diabetes, or a family history of kidney issues, ask if a urine albumin check could help clarify your heart risk.
-
Risk is a Conversation, Not a Sentence: A 10-year risk score is a probability. If your score is 10%, it doesn’t mean you will have a heart attack; it means that out of 100 people like you, 10 likely will. This number should be the start of a conversation about diet, exercise, and whether medication is the right choice for your lifestyle.
Limitations of the Research
While the study is historic in scale, it does have gaps. There was a notable under-representation of data from Africa and parts of the Middle East. Experts call for more inclusive research in these regions to ensure the algorithms work equally well for all ethnicities and backgrounds. Furthermore, for patients who already have advanced heart disease, these calculators are less effective, as their clinical needs are already established.
The Bottom Line
The validation of PREVENT and SCORE2 marks a milestone in global health. By proving these tools work across borders—and highlighting how a simple urine test can make them even better—the medical community has moved one step closer to a world where heart disease is caught and countered long before it becomes a crisis.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
- https://www.earth.com/news/doctors-worldwide-may-finally-have-a-reliable-way-to-predict-heart-risk/
